The formation of AFB1-macromolecular adducts in rats and humans at dietary levels of exposure

Food and Chemical Toxicology

Volumn 42, Issue 4, 2004, Pages 559-569

  Cupid, B C ^a   Lightfoot, T J ^a   Russell, D ^a   Gant, S J ^a   Turner, P C ^b   Dingley, K H ^c   Curtis, K D ^c   Leveson, S H ^d   Turteltaub, K W ^f   Garner, R C ^a,e  

^a UNIVERSITY OF YORK   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c LAWRENCE LIVERMORE NATIONAL LABORATORY   (United States)

^d YORK HOSPITAL   (United Kingdom)

^e Xceleron Ltd   (United Kingdom)

^f NONE

Author keywords

Accelerator mass spectroscopy; Adducts; AFB1, aflatoxin B1; Aflatoxin; AMS, accelerator mass spectrometry; B.w., body weight; LLNL, Lawrence Livermore National Laboratory; Low dose; Risk assessment

Indexed keywords

AFLATOXIN B1; ALBUMIN; CARBON 14; DNA;

ALBUMIN BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; COLON; COLON SURGERY; CONTROLLED STUDY; DNA ADDUCT; DNA DETERMINATION; DOSE RESPONSE; DOSIMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; KIDNEY; LINEAR REGRESSION ANALYSIS; LIVER; LUNG; MACROMOLECULE; MALE; NONHUMAN; PROTEIN HYDROLYSIS; RAT; SPLEEN; TISSUE DISTRIBUTION;

AFLATOXIN B1; AFLATOXINS; ALBUMINS; ANIMALS; CARCINOGENS; DIET; DNA ADDUCTS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MALE; MASS SPECTROMETRY; RATS; RATS, INBRED F344; RISK ASSESSMENT; SCINTILLATION COUNTING;

EID: 12144291342     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2003.10.015     Document Type: Article

References (40)

1. 1 in rats at very low exposures. Cancer Res. 42:1982;3659-3662.
2. 1-DNA adducts formed in cultured human bronchus and colon. Cancer Res. 39:1979;694-698.
3. 1. the ultimate carcinogenic species J. Amer. Chem. Soc. 110:1988;7929-7931.
4. 1. Carcinogenesis. 11:1990;2133-2135.
5. Chapot B., Wild C.P. ELISA for quantitation of aflatoxin-albumin adducts and their application to human exposure. Techn Diagnost Path. 1991;2.
6. 1. Eaton D.L., Groopman J.D. The Toxicology of Aflatoxins: Human Health, Veterinary and Agricultural Significance. 1994;89-101 Academic Press, London.
7. 1-DNA adduct formed in vivo in rat liver. Proc. Natl. Acad. Sci. 75(4):1978;1745-1749.
8. Dingley K.H., Curtis K.D., Nowell S., Felton J.S., Lang N.P., Turteltaub K.W. DNA and protein adduct formation in the colon and blood of humans after exposure to a dietary relevant dose of 2-amino-1-methyl-6-phenylimidazo[4,5-b] pyridine. Cancer Epidem. Biom. Prev. 8:1999;507-512.
9. Eaton D.L., Groopman J.D. The Toxicology of Aflatoxins. Human Health, Veterinary and Agricultural Significance. 1994;Academic Press, London.
10. 1 in vitro. Proc. Natl. Acad. Sci. 74:1977;1870-1874.
11. Frantz C.E., Bangerter C., Fultz E., Mayer K.W., Vogel J.S. Dose-response studies of MeIQx in rat liver and liver DNA at low doses. Carcinogenesis. 16:1995;367-373.
12. Freeman S.P.H.T., Serfass R.E., King J.C., Southon J.R., Fang Y., Woodhouse L.R., Bench G.S., Mcaninch J.E. Biological sample preparation and Ca-41 AMS measurement at LLNL. Nucl. Inst. Mth. Phys. B. 99:1995;557-561.
13. Freeman S.P.H.T., Vogel J.S. Biomedical accelerator mass spectrometry. Int. J. Mass. Spec. 143:1995;247-256.
14. 1 Carcinogenesis. 9:1998;1323-1325.
15. 1 causes guanine substitution in nucleic acids. Nature. 5614:1977;863-865.
16. Groopman J.D. Chapter 12 - molecular dosimetry methods for assessing human aflatoxin exposures. Eaton D.L., Groopman J.D. The Toxicology of Aflatoxins: Human Health, Veterinary and Agricultural Significance. 1994;259-280 Academic Press, London.
17. 1. Carcinogenesis. 3:1982;723-725.
18. IARC Monograph on Aflatoxin. 1993;IARC, World Health Organisation, Lyon.
19. 1-adduct formation in rat and human small bowel enterocytes. Gastroenterology. 106:1994;433-439.
20. 1 in fetal, infant and adult rats. Chem.-Biol. Interact. 94:1995;1-19.
21. 1-DNA or ribosomal RNA adducts formed in hepatic microsome-mediated reactions and in rat liver in vivo. Cancer Res. 37:1977;4430-4438.
22. Lutz W.K. Quantitative evaluation of DNA binding data for risk estimation and for classification of direct and indirect carcinogens. J. Cancer Res. Clin. Oncol. 112:1986;85-91.
23. 14C]benzene in rodents, using accelerator mass spectrometry. Toxicol. Appl. Pharmacol. 159:1999;83-90.
24. Mauthe R.J., Dingley K.H., Leveson S.H., Freeman S.P.H.T., Turesky R.J., Garner R.C., Turteltaub K.W. Comparison of the DNA-adduct and tissue-available dose levels of MeIQx in human and rodent colon following administration of a very low dose. Int. J. Cancer. 80:1999;539-545.
25. Montesano R., Hainaut P., Wild C.P. Hepatocellular carcinoma. from gene to public health J Nat. Cancer Inst. 89(24):1997;1844-1851.
26. Murray R.W., Jeyaraman R. Dioxiranes. Synthesis and reactions of methyldioxiranes J. Org. Chem. 50:1985;2847-2853.
27. Newberne P.M., Rogers A.E. Rat colon carcinomas associated with aflatoxin and marginal Vitamin A. J. Nat. Cancer. Instit. 50:1973;439-448.
28. 1-DNA adduct formation in the rat in vivo and in vitro. the use of immunoslot blotting for adduct quantitation Teratog. Carcinog. & Mutag. 19:1999;157-170.
29. Poirier M.C., Santella R.M., Weston A. Carcinogen macromolecular adducts and their measurement. Carcinogenesis. 21(3):2000;353-359.
30. 1 in vivo in rats. Carcinogenesis. 8:1987;819-824.
31. 1 and their implications for the quantification in biological samples. Chem.-Biol. Interact. 75:1990;1-15.
32. Skipper P.L., Tannenbaum S.R. Commentary. protein adducts in the molecular dosimetry of chemical carcinogens Carcinogenesis. 11(4):1990;507-518.
33. 1 exposure in the UK Cancer Epidem. Biom. Prev. 7:1998;441-447.
34. Turteltaub K.W., Felton J.S., Gledhill B.L., Vogel J.S., Southon J.R., Caffee M.W., Finkel R.C., Nelson D.E., Proctor I.D., Davis J.C. Accelerator mass spectrometry in biomedical dosimetry. relationship between low-level exposure and covalent binding of heterocyclic amine carcinogens to DNA Proc. Nat. Acad. Sci. 87:1990;5288-5292.
35. Vogel J.S. Rapid production of graphite without contamination for biomedical accelerator mass spectrometry. Radiocarbon. 43:1992;344-350.
36. Vogel J.S., Turteltaub K.W. Accelerator mass-spectrometry in biomedical-research. NIMB. 92:1994;445-453.
37. Wang J., Qian G., Zarba A., He X., Zhu Y., Zhang B., Jacobson L.P., Gange S.J., Munoz A., Kensler T.W., Groopman J.D. Temporal patterns of aflatoxin-albumin adducts in hepatitus B surface antigen-positive and antigen-negative residents of Daxin, Qidong County, People's Republic of China. Cancer Epidem. Biom. Prev. 5:1996;253-261.
38. 1 binding to plasma albumin and liver DNA upon chronic administration to rats. Carcinogenesis. 7:1986;853-858.
39. Wild C.P., Jiang Y., Sabbioni G., Chapot B., Montesano R. Evaluation of methods for quantitation of aflatoxin-albumin adducts and their application of human exposure assessment. Cancer Res. 50:1990;245-251.
40. Wild C.P., Hasewega R., Barraud L., Chutimataewin S., Chapot B., Ito N., Montesano R. Aflatoxin albumin adducts. a basis for comparative carcinogenesis between animals and humans Cancer Epidem. Biom. Prev. 5:1996;179-189.